Total planned funding: $155,360,788
Allocations
Countries/Regions
Eswatini | $155,360,788 |
Organizational Types
NGO | $42,224,610 |
Private Contractor | $36,505,357 |
University | $28,802,629 |
Unknown | $20,536,814 |
Own Agency | $17,595,035 |
Host Country Government Agency | $5,443,560 |
Multi-lateral Agency | $2,083,840 |
Other USG Agency | $1,256,843 |
FBO | $742,500 |
Implementing Agency | $169,600 |
Program Areas
Care | $46,463,832 |
Prevention | $35,639,929 |
Treatment | $29,614,185 |
Governance and Systems | $21,819,405 |
Management and Operations | $11,315,051 |
Testing | $10,508,386 |
Budget Codes
HTXS: Treatment: Adult Treatment | $24,053,135 |
HBHC: Care: Adult Care and Support | $21,376,956 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $13,934,599 |
HKID: Care: Orphans and Vulnerable Children | $13,100,164 |
HVMS: Management and Operations | $11,315,051 |
HVCT: Testing: HIV Testing and Counseling | $10,508,386 |
HVSI: Strategic Information | $9,272,126 |
OHSS: Health Systems Strengthening | $8,483,737 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $8,155,199 |
HVTB: Care: TB/HIV | $7,260,461 |
HVOP: Sexual Prevention: Other Sexual Prevention | $6,458,450 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $5,576,681 |
PDCS: Care: Pediatric Care and Support | $4,726,251 |
HLAB: Laboratory Infrastructure | $4,063,542 |
HTXD: Treatment: ARV Drugs | $2,989,187 |
PDTX: Treatment: Pediatric Treatment | $2,571,863 |
HMBL: Biomedical Prevention: Blood Safety | $1,515,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$26,052,238
Countries/Regions
Not Available:
$20,033,827
Countries/Regions
Pact, Inc.:
$19,363,141
Countries/Regions
USG Aggregated Agencies:
$14,651,407
Countries/Regions